Bloodstream infections (BSIs) represent a significant challenge in the treatment of acute ischemic stroke (AIS), often exacerbating patient morbidity and mortality. The increasing adoption of endovascular thrombectomy (EVT) as a first-line treatment for selected AIS patients necessitates a concurrent focus on minimizing the risk of these infections. This article explores the role of the "Hermes" system (a hypothetical system, as no such system currently exists under this name; this article uses "Hermes" as a placeholder for a future or advanced endovascular thrombectomy system) in improving EVT outcomes while simultaneously mitigating the risk of BSIs. We will examine the potential benefits of a hypothetical "Hermes" system within the context of existing endovascular thrombosis management and lancet-based EVT technologies.
Hermes Endovascular Thrombosis: A Hypothetical System Focused on Infection Control
The hypothetical "Hermes" system represents a paradigm shift in endovascular thrombosis management. Current EVT procedures, while highly effective in restoring blood flow to ischemic brain tissue, carry an inherent risk of BSIs. This risk stems from several factors:
* Vascular access: Femoral artery puncture, the most common access site for EVT, creates a potential entry point for pathogens.
* Device manipulation: Introduction of catheters, guidewires, and thrombectomy devices into the vascular system carries a risk of introducing bacteria or other microorganisms.
* Procedure duration: Longer procedures increase the risk of infection.
* Patient comorbidities: Patients with pre-existing conditions such as diabetes, immunosuppression, or chronic kidney disease are at higher risk of developing BSIs.
The hypothetical "Hermes" system aims to address these challenges through several innovative features:
* Minimally invasive access techniques: The system might incorporate techniques like transradial access (access via the radial artery in the wrist), which has been shown to reduce the risk of bleeding and infection compared to femoral access. This could involve smaller sheath sizes and specialized guide catheters designed for optimal radial access.
* Antimicrobial coatings: All components of the "Hermes" system, including catheters, guidewires, and thrombectomy devices, could be coated with antimicrobial agents. These coatings could be designed to release antimicrobial substances slowly over time, providing sustained protection against bacterial growth. The choice of antimicrobial agent would need to be carefully considered to minimize the risk of antibiotic resistance.
* Closed system technology: The system could incorporate closed system technology to minimize exposure of the vascular system to the external environment. This could involve using sealed connectors and minimizing the need for manual manipulation during the procedure.
* Real-time infection detection: The "Hermes" system might incorporate sensors to detect the presence of bacteria or other microorganisms in the blood during the procedure. This would allow for immediate intervention if an infection is detected, potentially preventing the development of a full-blown BSI.
* Improved procedural efficiency: Streamlined design and advanced features could lead to shorter procedure times, further reducing the risk of infection. This might include features like improved thrombectomy device maneuverability and enhanced imaging capabilities for precise targeting.
Lancet Endovascular Thrombectomy: Integration with the Hermes System
Lancet-based EVT devices have emerged as a significant advancement in the field. Their design, often featuring a smaller profile and improved aspiration capabilities, can contribute to improved procedural efficiency and reduced trauma to the vessel wall. The hypothetical "Hermes" system would be ideally suited for integration with lancet-based devices. The smaller profile of lancet devices could further enhance the benefits of transradial access, while the antimicrobial coatings and closed system technology would still provide crucial infection control.
current url：https://gbpzqe.e351c.com/guide/hermes-stroke-lancet-42232